<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03316391</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0517</org_study_id>
    <nct_id>NCT03316391</nct_id>
  </id_info>
  <brief_title>Association Between Pococyturia and Pre-eclampsia Severity</brief_title>
  <acronym>PEPOD2</acronym>
  <official_title>Prospective Study : Association Between Pococyturia and Pre-eclampsia Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious&#xD;
      maternal, fetal and neonatal mortality and morbidity. Twenty four hours proteinuria is a key&#xD;
      element to define pre-eclampsia severity but is delaying the result by 24 hours and&#xD;
      constraining for the patient. A simple and rapid indicator for severe preeclampsia would help&#xD;
      clinicians to make appropriate decision in patient management. We hypothesized that urinary&#xD;
      podocyturia is correlated to preeclampsia severity. This is a prospective,&#xD;
      non-interventional, monocentric study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2019</start_date>
  <completion_date type="Anticipated">March 22, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 22, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of pre-eclampsia</measure>
    <time_frame>at childbirth (maximum 10 months)</time_frame>
    <description>Severe preeclampsia is defined by preeclampsia with at least one of the following criteria :&#xD;
severe hypertension (PAS ≥ 160 mmHg et/ou PAD ≥ 110 mmHg)&#xD;
Renal impairment with: oliguria &lt;500 ml / 24h or creatinine&gt; 135 μmol / L or proteinuria&gt; 5 g/d&#xD;
acute lung edema or persistent epigastric bar or HELLP syndrome&#xD;
eclampsia or rebellious neurological disorders (visual disturbances, polykinetic ROT, headache),&#xD;
thrombocytopenia &lt;100 G / L&#xD;
Retro Placental Hematoma (HRP) or fetal repercussion.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pre-Eclampsia</condition>
  <arm_group>
    <arm_group_label>Pre-eclampsia</arm_group_label>
    <description>Patients in hospital for pre-eclampsia at the Hopital Femme-Mère-Enfant</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dosage of urinary podocyturia</intervention_name>
    <description>Dosage of urinary podocyturia at admission, delivery and post-partum visit</description>
    <arm_group_label>Pre-eclampsia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in hospital for pre-eclampsia at the Hopital Femme-Mère-Enfant&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women aged 18 years or more&#xD;
&#xD;
          -  single pregnancy&#xD;
&#xD;
          -  admission for pre-eclampsia&#xD;
&#xD;
          -  patient receiving information and non-opposition to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  multiple pregnancy&#xD;
&#xD;
          -  in utero fetal demise excepted if associated with pre-eclampsia&#xD;
&#xD;
          -  antecedent of nephropathy&#xD;
&#xD;
          -  fetal malformation, chromosomal anomalies&#xD;
&#xD;
          -  inability to understand information provided&#xD;
&#xD;
          -  prisoner or under administrative supervision&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Muriel DORET-DION, MD</last_name>
    <phone>04 27 85 51 70</phone>
    <phone_ext>+33</phone_ext>
    <email>muriel.doret-dion@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of obstetrics, Femme Mère Enfant Hospital, Lyon, France</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muriel DORET-DION, MD</last_name>
      <phone>04 27 85 51 70</phone>
      <phone_ext>+33</phone_ext>
      <email>muriel.doret-dion@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 17, 2017</study_first_submitted>
  <study_first_submitted_qc>October 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2017</study_first_posted>
  <last_update_submitted>October 22, 2019</last_update_submitted>
  <last_update_submitted_qc>October 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

